Tilray Brands, Inc. Common Stock (TLRY)
Tilray Brands, Inc. is a global leader in the production and distribution of medical cannabis, adult-use cannabis, and wellness products. Founded in 2013, the company operates through various subsidiaries and brands, offering a range of cannabis products, including cannabis flowers, oils, and edibles, to both medical and recreational markets worldwide. Tilray emphasizes research, quality, and innovation within the rapidly evolving cannabis industry.
Company News
Breckenridge Brewery received Silver Certification from the Colorado Green Business Network for its sustainability efforts, including solar panel usage, water recycling, and 99% waste diversion.
Tilray Brands stock has rallied over 133% in three months, driven by market anticipation of potential U.S. cannabis rescheduling from Schedule I to Schedule III, which could dramatically improve the financial landscape for cannabis operators.
An analysis of Tilray's stock performance over the past five years reveals a significant decline, with a $1,000 investment shrinking to $163. Despite potential opportunities in cannabis legalization and business diversification, the company remains unprofitable and faces uncertain market conditions.
The cannabis industry saw significant developments this week, including New York reaching $1 billion in sales, Tilray reporting earnings, DoorDash expanding into hemp-derived products, and Ukraine registering its first medical cannabis product.
Tilray Brands reported Q4 2024 revenue of $229.88 million, up 24.8% year-over-year, and EPS of -$0.04 compared to $0.00 in the prior year. The company's performance was mixed compared to analyst estimates, with revenue beating expectations but EPS missing.
